Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Havemann

Showing results (261-270 of 325) with videos related to

Pageof 33
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Expression of bcl-2--protein in small cell lung cancerU Kaiser, M Schilli, U Haag, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 1996
[Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma]M Wolf, C Faoro, C Görg, et al.
International Journal of Cancer|June 15, 1990
Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol esterU Salge, P Kilian, K Neumann, et al.
Nephron|January 1, 1991
Hemodialysis and blood coagulation: the effect of hemodialysis on coagulation factor XIII and thrombin-antithrombin III complexG Kolb, W Fischer, R Seitz, et al.
Sozial- Und Praventivmedizin|January 1, 1993
Increased risk of acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML) in a county of Hesse, GermanyG Kolb, N Becker, S Scheller, et al.
Experimental Cell Research|October 1, 1989
Production of insulin-like growth factor binding proteins by small-cell lung cancer cell linesG Jaques, P Kiefer, M Rotsch, et al.
Cancer Research|March 1, 1988
Epidermal growth factor receptor expression in human lung cancer cell linesM Haeder, M Rotsch, G Bepler, et al.
Blut|December 1, 1976
[Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate]R Egbring, K Andrassy, K Havemann, et al.
Anticancer Research|September 1, 1993
Modulation of lectin-triggered superoxide release from neutrophils of tumor patients with and without chemotherapyA V Timoshenko, K Kayser, P Drings, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Plasma derivative replacement therapy in diss. intravasc.coag.(DIC) induced by septic disorders with highly elevated elastase alpha 1AT-complexesR Egbring, R Seitz, M Wolf, et al.
Pageof 33

Showing results (261-270 of 325) with videos related to

Sort By:
Pageof 33
Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Expression of bcl-2--protein in small cell lung cancerU Kaiser, M Schilli, U Haag, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 1996
[Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma]M Wolf, C Faoro, C Görg, et al.
International Journal of Cancer|June 15, 1990
Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol esterU Salge, P Kilian, K Neumann, et al.
Nephron|January 1, 1991
Hemodialysis and blood coagulation: the effect of hemodialysis on coagulation factor XIII and thrombin-antithrombin III complexG Kolb, W Fischer, R Seitz, et al.
Sozial- Und Praventivmedizin|January 1, 1993
Increased risk of acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML) in a county of Hesse, GermanyG Kolb, N Becker, S Scheller, et al.
Experimental Cell Research|October 1, 1989
Production of insulin-like growth factor binding proteins by small-cell lung cancer cell linesG Jaques, P Kiefer, M Rotsch, et al.
Cancer Research|March 1, 1988
Epidermal growth factor receptor expression in human lung cancer cell linesM Haeder, M Rotsch, G Bepler, et al.
Blut|December 1, 1976
[Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate]R Egbring, K Andrassy, K Havemann, et al.
Anticancer Research|September 1, 1993
Modulation of lectin-triggered superoxide release from neutrophils of tumor patients with and without chemotherapyA V Timoshenko, K Kayser, P Drings, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Plasma derivative replacement therapy in diss. intravasc.coag.(DIC) induced by septic disorders with highly elevated elastase alpha 1AT-complexesR Egbring, R Seitz, M Wolf, et al.
Pageof 33